Lataa...
The role of acalabrutinib in adults with chronic lymphocytic leukemia
The treatment landscape of chronic lymphocytic leukemia (CLL) has significantly changed in the past decade. This paradigm shift is due to the introduction of novel agents to the field. The two major classes of drugs that have contributed to this dramatic evolution include the Bruton tyrosine kinase...
Tallennettuna:
| Julkaisussa: | Ther Adv Hematol |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
SAGE Publications
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7871059/ https://ncbi.nlm.nih.gov/pubmed/33613932 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2040620721990553 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|